![]() |
市场调查报告书
商品编码
1663307
医用气体压力调节器全球市场:洞察、竞争格局及市场预测:2032年Medical Gas Pressure Regulators - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
预计医用气体压力调节器市场规模在预测期内(即2025-2032年)将以 5.13%的年复合成长率成长。医用气体压力调节器的需求主要受到心血管疾病和癌症等慢性疾病全球盛行率不断上升的推动。这些情况通常需要长期治疗、手术和氧气治疗,因此对医疗环境中可靠且精确的气压控制的需求也随之增加。疾病负担和医疗成本的不断上升刺激了医院、诊所和家庭医疗服务的扩张,推动了对包括压力调节器在内的医用气体系统的需求。随着越来越多的医疗服务转向家庭护理,对便携式、易于使用的医用气体设备的需求显着增加,这些设备可确保在传统临床环境之外向患者安全有效地输送气体。
此外,该领域的技术进步在市场成长中发挥关键作用。数位压力调节器、自动流量控制系统和增强的安全功能等技术创新提高了设备的效率、准确性和病患安全性。这些进步不仅增强了使用者体验,而且扩大了医用气体压力调节器在各种医疗程序和护理环境中的应用。
考虑到这些市场驱动因素,由于疾病盛行率不断上升、医疗保健基础设施不断扩大以及医疗器材製造技术不断进步,预计医用气体压力调节器市场将在2025-2032年预测期内实现显着成长。
本报告研究了全球医用气体压力调节器市场,并概述了市场以及依类型、产品、最终用户和地区划分的趋势,以及参与市场的公司概况。
Medical Gas Pressure Regulators Market by Type (Oxygen Pressure Regulators, Nitrous Oxide Pressure Regulators, Medical Air Pressure Regulators, and Others), Product (Single Stage Regulators and Dual Stage Regulators), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of chronic diseases such as cardiovascular diseases & cancer and growing healthcare expenditure resulting in rise in hospitals, clinics, and home healthcare.
The Medical Gas Pressure Regulators market is estimated to grow at a CAGR of 5.13% during the forecast period from 2025 to 2032. The demand for medical gas pressure regulators is primarily driven by the rising prevalence of chronic diseases such as cardiovascular diseases and cancer worldwide. These conditions often require long-term treatments, surgeries, and oxygen therapy, thereby increasing the need for reliable and precise gas pressure regulation in healthcare settings. In addition to the growing disease burden, increasing healthcare expenditure is fueling the expansion of hospitals, clinics, and home healthcare services, which, in turn, is propelling the demand for medical gas systems, including pressure regulators. As more healthcare services shift towards home-based care, there is a notable surge in the demand for portable and user-friendly medical gas equipment that ensures safe and efficient gas delivery for patients outside traditional clinical environments.
Furthermore, technological advancements in the field are playing a pivotal role in market growth. Innovations such as digital pressure regulators, automatic flow control systems, and enhanced safety features are improving device efficiency, accuracy, and patient safety. These advancements are not only enhancing user experience but also expanding the application scope of medical gas pressure regulators across various medical procedures and care settings.
Given these favorable market drivers, the medical gas pressure regulators market is expected to witness significant growth during the 2025 to 2032 forecast period, driven by the convergence of rising disease prevalence, healthcare infrastructure expansion, and technological progress in medical device manufacturing.
Medical Gas Pressure Regulators Market Dynamics:
According to the British Heart Foundation (2024), approximately 620 million people worldwide are living with heart and circulatory diseases, with an estimated 1 in 13 individuals affected globally. Similarly, the World Health Organization (WHO, 2024) reported 20 million new cancer cases in 2022, with the global cancer burden projected to increase by 77% by 2050. These alarming statistics underscore the rising prevalence of chronic diseases, which often necessitate prolonged treatment periods, frequent surgeries, and long-term therapeutic interventions.
Patients with cardiovascular conditions or advanced-stage cancers frequently require long-term oxygen therapy and precise medical gas delivery for supportive care. This trend has led to a sustained demand for reliable and accurate gas pressure regulation systems, as medical gas pressure regulators play a vital role in ensuring safe and consistent gas flow in various treatment settings.
Another significant growth driver for the medical gas pressure regulators market is the increasing global healthcare expenditure, which has spurred the development of new hospitals, clinics, surgical centers, and home healthcare services. Higher healthcare spending facilitates the installation of advanced medical gas systems in healthcare facilities to support critical services such as oxygen therapy, anesthesia administration, and respiratory care. Surgical centers, in particular, rely heavily on precise gas flow control to ensure patient safety during complex procedures.
Furthermore, the growing trend toward home-based healthcare has accelerated the demand for portable and user-friendly medical gas equipment. Patients requiring long-term care at home depend on compact medical gas regulators that provide accurate pressure control to maintain therapeutic efficacy and safety. The shift toward personalized patient care and minimally invasive treatments has further strengthened this demand, particularly among elderly populations and individuals managing chronic illnesses outside traditional hospital settings.
Despite these growth opportunities, certain challenges persist. Regular calibration and maintenance are essential to ensure the accuracy and longevity of medical gas pressure regulators, which can pose operational burdens for healthcare providers. Additionally, the risk of equipment malfunction if not properly maintained may compromise patient safety, thereby acting as a potential constraint on market growth.
Nonetheless, the combined effects of rising chronic disease prevalence, increased healthcare spending, and the expansion of healthcare infrastructure are expected to drive significant growth in the medical gas pressure regulators market during the 2025 to 2032 forecast period.
Medical Gas Pressure Regulators Market Segment Analysis:
Medical Gas Pressure Regulators Market by Type (Oxygen Pressure Regulators, Nitrous Oxide Pressure Regulators, Medical Air Pressure Regulators, and Others), Product (Single Stage Regulators and Dual Stage Regulators), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the type segment of the medical gas pressure regulators market, the oxygen pressure regulators category is projected to capture a significant revenue share in 2024. This growth is primarily driven by the increasing prevalence of respiratory disorders and the broad range of applications associated with oxygen therapy.
According to a 2023 study published by the American Medical Association, approximately 480 million people worldwide were living with chronic obstructive pulmonary disease (COPD) in 2020. The study further projected that the number of COPD cases will rise by an additional 112 million, reaching a total of 592 million cases by 2050. Respiratory conditions such as COPD, asthma, pneumonia, and acute respiratory distress syndrome (ARDS) often necessitate oxygen therapy as a critical component of patient care. Oxygen pressure regulators are essential in these treatments, as they ensure precise and consistent oxygen delivery, improving patient safety and therapeutic efficacy.
Additionally, the COVID-19 pandemic has heightened global awareness of respiratory health, further accelerating the demand for oxygen pressure regulators in both hospital settings and home-based oxygen therapy. The growing geriatric population, which is more susceptible to chronic respiratory illnesses, also contributes to the rising need for reliable oxygen delivery systems.
Technological advancements in oxygen regulators such as portable devices, digital pressure indicators, and auto-adjustment features have enhanced patient convenience and broadened the application of these devices beyond hospitals to ambulatory services, home care, and emergency response systems.
Given these factors, the oxygen pressure regulators segment is expected to witness significant growth during the 2025 to 2032 forecast period, thereby driving the overall expansion of the medical gas pressure regulators market.
North America is expected to dominate the overall medical gas pressure regulators market:
North America is projected to account for the largest share of the medical gas pressure regulators market in 2024, driven by several key factors, including the increasing prevalence of chronic diseases, advanced healthcare infrastructure, and aging population.
According to the Centers for Disease Control and Prevention (CDC), 2024, approximately 1 in 20 adults aged 20 years or older in the United States suffers from coronary artery disease (CAD). Additionally, around 805,000 people in the U.S. experience a heart attack annually. Patients with cardiac conditions such as heart failure and myocardial infarction often require supplemental oxygen therapy to alleviate symptoms, reduce the heart's workload, and improve oxygenation during acute cardiac events. This reliance on oxygen therapy significantly contributes to the demand for medical gas pressure regulators in clinical settings.
In parallel, the rising cancer burden is further propelling market growth. As per GLOBOCAN 2022, approximately 2.6 million people in North America were living with cancer. Oxygen therapy is commonly used in lung cancer patients and individuals with metastatic disease affecting the lungs to manage respiratory complications. Additionally, oxygen plays a crucial role during surgeries and cancer treatments, increasing the need for precise gas pressure regulation.
Respiratory diseases are another major factor driving market demand. According to the CDC, 2023 data, an estimated 14.2 million U.S. adults (6.5% of the population) were diagnosed with chronic obstructive pulmonary disease (COPD) in 2021. COPD patients frequently require long-term oxygen therapy to enhance their quality of life, which necessitates the use of reliable medical gas pressure regulators to ensure safe and consistent oxygen delivery.
The aging population in North America further compounds these trends, as older adults are more susceptible to chronic diseases and respiratory disorders, increasing the overall demand for oxygen therapy in both hospital and home healthcare settings.
Moreover, North America's sophisticated healthcare infrastructure facilitates early disease diagnosis, higher rates of surgical interventions, and the adoption of advanced medical devices, further boosting the use of medical gas pressure regulators. The growing emphasis on home healthcare services, coupled with technological advancements in portable and user-friendly devices, is also expanding the market.
Given these favorable market dynamics, North America is expected to maintain its leading position in the medical gas pressure regulators market during the 2025 to 2032 forecast period.
Medical Gas Pressure Regulators Market Key Players:
Some of the key market players operating in the medical gas pressure regulators market include Air Liquide, Silbermann, GCE Group, Rotarex, Spencer, PrecisionMedical, Honeywell International Inc., GENSTAR TECHNOLOGIES, Amico Group of Companies, Essex Industries, Inc., Mediline Engineers, AmcareMed Medical Gas System, MATHESON TRI-GAS, INC., SOLGROUP, Control Devices. LLC., BPR Medical, MEC Medical Limited, Ohio Medical, Perfect Medical Products, and Hunan Eter Medical Co., Ltd.
Recent Developmental Activities in the Medical Gas Pressure Regulators Market:
Key Takeaways from the Medical Gas Pressure Regulators Market Report Study
Target Audience Who Can be Benefited from this Medical Gas Pressure Regulators Market Report Study
Frequently Asked Questions for the Medical Gas Pressure Regulators Market: